Works matching DE "CONVALESCENT plasma"
Results: 1234
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
- Published in:
- PLoS Medicine, 2021, v. 18, n. 10, p. 1, doi. 10.1371/journal.pmed.1003769
- By:
- Publication type:
- Article
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
- Published in:
- PLoS Medicine, 2021, v. 17, n. 3, p. 1, doi. 10.1371/journal.pmed.1003415
- By:
- Publication type:
- Article
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
- Published in:
- 2021
- By:
- Publication type:
- Journal Article
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
COVID-19 pneumonia, immunosuppression, and cytomegalovirus activation: A perspective.
- Published in:
- Journal of Postgraduate Medicine, 2021, v. 67, n. 2, p. 65, doi. 10.4103/jpgm.JPGM_55_21
- By:
- Publication type:
- Article
Convalescent plasma, cytomegalovirus infection, and persistent leukopenia in COVID-19 recovery phase: What is the link?
- Published in:
- Journal of Postgraduate Medicine, 2021, v. 67, n. 2, p. 100, doi. 10.4103/jpgm.JPGM_1168_20
- By:
- Publication type:
- Article
Perplexing issues for convalescent immune plasma therapy in COVID-19.
- Published in:
- Northern Clinics of Istanbul, 2021, v. 8, n. 6, p. 634, doi. 10.14744/nci.2021.73604
- By:
- Publication type:
- Article
Changes in Plasma Amino Acid Levels in Crimean-Congo Hemorrhagic Fever Patients.
- Published in:
- European Journal of Therapeutics, 2024, v. 30, n. 5, p. 682, doi. 10.58600/eurjther2112
- By:
- Publication type:
- Article
An evaluation of the results of convalescent plasma therapy applied to pregnant women diagnosed as COVID-19-positive in a pandemic center: A prospective cohort study.
- Published in:
- Turkish Journal of Medical Sciences, 2022, v. 52, n. 3, p. 554, doi. 10.55730/1300-0144.5346
- By:
- Publication type:
- Article
An update of anti-viral treatment of COVID-19.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, p. 3372, doi. 10.3906/sag-2106-250
- By:
- Publication type:
- Article
Perspectives for immune plasma treatment of COVID-19.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 1, p. 1, doi. 10.3906/sag-2005-410
- By:
- Publication type:
- Article
Efficacy of convalescent plasma according to blood groups in COVID-19 patients.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 1, p. 45, doi. 10.3906/sag-2007-59
- By:
- Publication type:
- Article
A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma.
- Published in:
- Turkish Journal of Medical Sciences, 2020, v. 50, n. 8, p. 1781, doi. 10.3906/sag-2009-77
- By:
- Publication type:
- Article
A Public Option for Clinical Trials? Lessons from Convalescent Plasma.
- Published in:
- Journal of Law, Medicine & Ethics, 2024, v. 52, n. 1, p. 98, doi. 10.1017/jme.2024.57
- By:
- Publication type:
- Article
A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 169, doi. 10.1007/s41030-020-00118-5
- By:
- Publication type:
- Article
Modelling the Relative Vaccine Efficacy of ARCT-154, a Self-Amplifying mRNA COVID-19 Vaccine, versus BNT162b2 Using Immunogenicity Data.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1161, doi. 10.3390/vaccines12101161
- By:
- Publication type:
- Article
Glycoprotein-Specific Polyclonal Antibodies Targeting Machupo Virus Protect Guinea Pigs against Lethal Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 674, doi. 10.3390/vaccines12060674
- By:
- Publication type:
- Article
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 459, doi. 10.3390/vaccines12050459
- By:
- Publication type:
- Article
Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1161, doi. 10.3390/vaccines11071161
- By:
- Publication type:
- Article
Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 637, doi. 10.3390/vaccines11030637
- By:
- Publication type:
- Article
SARS-CoV-2: An Updated Review Highlighting Its Evolution and Treatments.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2145, doi. 10.3390/vaccines10122145
- By:
- Publication type:
- Article
Therapeutic Role of Neutralizing Antibody for the Treatment against SARS-CoV-2 and Its Emerging Variants: A Clinical and Pre-Clinical Perspective.
- Published in:
- Vaccines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/vaccines10101612
- By:
- Publication type:
- Article
Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 743, doi. 10.3390/vaccines10050743
- By:
- Publication type:
- Article
Natural Brucella melitensis Infection and Rev. 1 Vaccination Induce Specific Brucella O-Polysaccharide Antibodies Involved in Complement Mediated Brucella Cell Killing.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 317, doi. 10.3390/vaccines10020317
- By:
- Publication type:
- Article
Immunization with GP1 but Not Core-like Particles Displaying Isolated Receptor-Binding Epitopes Elicits Virus-Neutralizing Antibodies against Junín Virus.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 173, doi. 10.3390/vaccines10020173
- By:
- Publication type:
- Article
Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1419, doi. 10.3390/vaccines9121419
- By:
- Publication type:
- Article
Overview of Neutralizing Antibodies and Their Potential in COVID-19.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1376, doi. 10.3390/vaccines9121376
- By:
- Publication type:
- Article
mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 918, doi. 10.3390/vaccines9080918
- By:
- Publication type:
- Article
Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 700, doi. 10.3390/vaccines9070700
- By:
- Publication type:
- Article
GspD, The Type II Secretion System Secretin of Leptospira , Protects Hamsters against Lethal Infection with a Virulent L. interrogans Isolate.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 759, doi. 10.3390/vaccines8040759
- By:
- Publication type:
- Article
Hematological aspects of the COVID-19 syndrome.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 12, p. 4463
- By:
- Publication type:
- Article
Convalescent plasma as a potential management option in COVID-19: a critical review of randomized controlled registered trials.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 24, p. 7976
- By:
- Publication type:
- Article
Plasma convalescent decrease mortality in COVID-19 patients: a systematic review and meta-analysis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 14, p. 4841
- By:
- Publication type:
- Article
2-Deoxy-D-glucose: is this the final cure for COVID-19: or yet another mirage?
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 13, p. 4448
- By:
- Publication type:
- Article
COVID-19 reinfection in the presence of neutralizing antibodies.
- Published in:
- National Science Review, 2021, v. 8, n. 4, p. 1, doi. 10.1093/nsr/nwab006
- By:
- Publication type:
- Article
Convalescent plasma transfusion in severe covid-19 patients admitted to intensive care unit: A single center study.
- Published in:
- Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2023, v. 40, n. 2, p. 258, doi. 10.52142/omujecm.40.2.11
- By:
- Publication type:
- Article
COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy.
- Published in:
- Transplant Infectious Disease, 2023, v. 25, p. 1, doi. 10.1111/tid.14144
- By:
- Publication type:
- Article
SARS‐CoV‐2 seropositivity in renal transplant patients administered intravenous immunoglobulin.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
High‐titer post‐vaccine COVID‐19 convalescent plasma for immunocompromised patients during the first omicron surge.
- Published in:
- Transplant Infectious Disease, 2023, v. 25, n. 2, p. 1, doi. 10.1111/tid.14055
- By:
- Publication type:
- Article
Uncovering hidden sources of SARS‐CoV‐2 viral evolution: A call to action.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 6, p. 1, doi. 10.1111/tid.13910
- By:
- Publication type:
- Article
Convalescent plasma treatment for early post‐kidney transplant acquired COVID‐19.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13685
- By:
- Publication type:
- Article
Treatment of immunocompromised COVID‐19 patients with convalescent plasma.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 2, p. 1, doi. 10.1111/tid.13477
- By:
- Publication type:
- Article
Successful recovery from COVID‐19 in three kidney transplant recipients who received convalescent plasma therapy.
- Published in:
- Transplant Infectious Disease, 2021, v. 23, n. 1, p. 1, doi. 10.1111/tid.13451
- By:
- Publication type:
- Article
COVID‐19 in recent heart transplant recipients: Clinicopathologic features and early outcomes.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 5, p. 1, doi. 10.1111/tid.13382
- By:
- Publication type:
- Article
The concentrated antibody from convalescent plasma balanced the dysfunctional immune responses in patients with critical COVID‐19.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 11, p. 1, doi. 10.1002/ctm2.571
- By:
- Publication type:
- Article
Persistent viral activity, cytokine storm, and lung fibrosis in a case of severe COVID‐19.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 7, p. 1, doi. 10.1002/ctm2.224
- By:
- Publication type:
- Article
Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1200289
- By:
- Publication type:
- Article
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1170759
- By:
- Publication type:
- Article